Arielle Lyon Langer, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schools, Medical | 2 | 2021 | 880 | 0.970 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2023 | 142 | 0.790 |
Why?
|
| Physiology | 1 | 2021 | 115 | 0.780 |
Why?
|
| von Willebrand Diseases | 1 | 2021 | 127 | 0.710 |
Why?
|
| Economics, Medical | 1 | 2019 | 113 | 0.690 |
Why?
|
| beta-Thalassemia | 1 | 2021 | 225 | 0.690 |
Why?
|
| Knowledge | 1 | 2021 | 181 | 0.680 |
Why?
|
| Science | 1 | 2021 | 241 | 0.670 |
Why?
|
| Teaching Rounds | 1 | 2021 | 253 | 0.610 |
Why?
|
| Hematology | 1 | 2020 | 221 | 0.610 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 337 | 0.590 |
Why?
|
| Antibodies, Bispecific | 1 | 2018 | 164 | 0.560 |
Why?
|
| Hemophilia A | 1 | 2018 | 351 | 0.520 |
Why?
|
| Cation Transport Proteins | 1 | 2017 | 327 | 0.490 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1127 | 0.480 |
Why?
|
| Anemia, Sickle Cell | 2 | 2019 | 1018 | 0.460 |
Why?
|
| Physicians, Primary Care | 1 | 2019 | 591 | 0.450 |
Why?
|
| Erythropoiesis | 1 | 2017 | 705 | 0.440 |
Why?
|
| Learning | 1 | 2021 | 1713 | 0.390 |
Why?
|
| Medicine | 1 | 2019 | 946 | 0.390 |
Why?
|
| Income | 1 | 2019 | 1913 | 0.380 |
Why?
|
| Anemia | 1 | 2017 | 1506 | 0.300 |
Why?
|
| Problem-Based Learning | 2 | 2021 | 361 | 0.290 |
Why?
|
| Telemedicine | 1 | 2023 | 2872 | 0.260 |
Why?
|
| Anticoagulants | 1 | 2020 | 4599 | 0.250 |
Why?
|
| Thrombosis | 1 | 2018 | 2968 | 0.250 |
Why?
|
| Macrophages | 1 | 2019 | 5655 | 0.240 |
Why?
|
| Educational Measurement | 2 | 2021 | 1210 | 0.230 |
Why?
|
| Pain | 1 | 2019 | 4986 | 0.230 |
Why?
|
| Love | 1 | 2023 | 36 | 0.220 |
Why?
|
| Cytokines | 1 | 2017 | 7322 | 0.210 |
Why?
|
| Activin Receptors, Type II | 1 | 2021 | 127 | 0.190 |
Why?
|
| Iron Chelating Agents | 1 | 2021 | 139 | 0.190 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2021 | 279 | 0.180 |
Why?
|
| Group Processes | 1 | 2021 | 225 | 0.170 |
Why?
|
| Chemokine CXCL11 | 1 | 2019 | 42 | 0.170 |
Why?
|
| Blood Coagulation Tests | 1 | 2020 | 263 | 0.170 |
Why?
|
| Chemokine CXCL9 | 1 | 2019 | 132 | 0.170 |
Why?
|
| Hematinics | 1 | 2021 | 281 | 0.170 |
Why?
|
| Hemolysis | 1 | 2020 | 420 | 0.160 |
Why?
|
| Demography | 1 | 2023 | 1656 | 0.150 |
Why?
|
| Interleukin-18 | 1 | 2019 | 249 | 0.150 |
Why?
|
| von Willebrand Factor | 1 | 2021 | 669 | 0.150 |
Why?
|
| Inflammation | 1 | 2017 | 10638 | 0.150 |
Why?
|
| Postpartum Period | 1 | 2023 | 1086 | 0.140 |
Why?
|
| Blood Coagulation Factors | 1 | 2018 | 355 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1105 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2023 | 1092 | 0.130 |
Why?
|
| Fetus | 1 | 2023 | 1880 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2021 | 1301 | 0.130 |
Why?
|
| Hemoglobins | 1 | 2020 | 1534 | 0.120 |
Why?
|
| Interleukin-10 | 1 | 2019 | 1200 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2021 | 2488 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2021 | 3772 | 0.110 |
Why?
|
| Humans | 14 | 2023 | 744343 | 0.110 |
Why?
|
| Amyloid | 1 | 2017 | 795 | 0.100 |
Why?
|
| Salvage Therapy | 1 | 2017 | 1275 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2021 | 1965 | 0.080 |
Why?
|
| Iron | 1 | 2017 | 1774 | 0.080 |
Why?
|
| Curriculum | 1 | 2021 | 3605 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2017 | 1886 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2018 | 3461 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 5137 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2017 | 9146 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5442 | 0.060 |
Why?
|
| United States | 2 | 2021 | 69872 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 8388 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 29144 | 0.050 |
Why?
|
| Female | 5 | 2023 | 380194 | 0.050 |
Why?
|
| Asthma | 1 | 2019 | 6011 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.040 |
Why?
|
| Adult | 4 | 2021 | 214055 | 0.040 |
Why?
|
| Hospitalization | 1 | 2017 | 10262 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 213383 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 85781 | 0.030 |
Why?
|
| New York | 1 | 2017 | 886 | 0.030 |
Why?
|
| Male | 4 | 2021 | 350118 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2017 | 1609 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8340 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2017 | 5102 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2017 | 7729 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29063 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 163280 | 0.000 |
Why?
|